Ymir Genomics & (OHSU) announce a licensing agreement and patent application covering miRNA biomarkers discovered utilizing Ymir’s extracellular vesicle isolation technology

October 22, 2020 Leave a comment

Ymir Genomics LLC (Ymir) and the Oregon Health & Science University (OHSU) Knight Cancer Institute today announced a licensing agreement and filed patent application that seeks to protect and promote newly-discovered high value urinary biomarkers for detecting cirrhosis and/or hepatocellular ...

Post-doc Position Available – Center for Early Detection Research

May 8, 2017 Leave a comment

Work Schedule, Hours, FTE, Salary Range FTE: 1.0 FTE, Full Time Schedule: Monday – Friday, 9:00 am – 5:00 pm Salary Range: Commensurate with Experience Location: Portland, OR (South Waterfront) Job Type: Postdoctoral Functions/Duties of Position Are you a highly ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Knight Cancer Institute

Ymir Genomics & (OHSU) announce a licensing agreement and patent application covering miRNA biomarkers discovered utilizing Ymir’s extracellular vesicle isolation technology

Post-doc Position Available – Center for Early Detection Research

Chloride ion channel ASOR is required for vesicle shrinkage

Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles

Damage-free and time-saving platform for continuous sorting and detection of exosomes and host cells in human serum

Predicine Liquid Biopsy Outperforms Four Other Leading ctDNA NGS Tests in a Study by Bristol Myers Squibb

Exosomes and their roles in the chemoresistance of pancreatic cancer

VivaZome to collaborate with the University of Queensland traumatic brain injury experts to develop exosome-based therapies